Pathnostics debuts COVID-19 PCR test

2020 05 20 19 37 8275 Pathnostics Nose Sample Test 400

CLIA-certified Pathnostics has launched a COVID-19 polymerase chain reaction (PCR) laboratory developed test that it is positioning as easy to administer, using a specimen from a simple nasal swab.

Pathnostics will perform its new test using Thermo Fisher Scientific's TaqPath reverse transcription (RT)-PCR COVID-19 kit, which received emergency use authorization from the U.S. Food and Drug Administration in March.

According to the company, the test evaluates three regions of the SARS-CoV 2 RNA, identifying the virus in 24 to 48 hours.

Page 1 of 23
Next Page